Depacon Trademark Details

Depacon was registered on Tuesday, December 8, 1998 and is currently owned by Sanofi under the registration number 2209652 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 15 years ago on Friday, January 23, 2009, according to the United State Patent & Trademark Office
Word Mark Depacon
Status Alive Registered 800 — Registered and Renewed

Current Owner

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi

Previous Owners

Sanofi-Aventis of Allen, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis

Sanofi-Synthelabo of Allen, TX

View all trademarks for Sanofi-Synthelabo
Other Trademarks for Sanofi-Synthelabo
Serial Number 75251980
Registration Number 2209652
Status Date Friday, January 23, 2009
Filing Date Friday, January 23, 2009
Registration Date Tuesday, December 8, 1998
Attorney Susan Upton Douglass
Domestic Representative Susan Upton Douglass

Correspondent

SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLAZA
NEW YORK NY 10017

Case File Statements

Goods & Services Pharmaceuticals Preparations for the Treatment of Central Nervous System Disturbances

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Saturday, March 22, 1997
First Use Anywhere Monday, April 7, 1997
First Use In Commerce Monday, April 7, 1997
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.